FDA.reportPublic FDA data

Xopenex 0.31 MG (as levalbuterol hydrochloride 0.36 MG) per 3 ML Inhalation Solution

RxCUI
352132
RxNorm name
Xopenex 0.31 MG (as levalbuterol hydrochloride 0.36 MG) per 3 ML Inhalation Solution
Display name
Xopenex 0.31 MG (as levalbuterol hydrochloride 0.36 MG) per 3 ML Inhalation Solution
Full name
Xopenex 0.31 MG (as levalbuterol hydrochloride 0.36 MG) per 3 ML Inhalation Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7e2644e6-36c5-4988-8e52-bec90e2cd2f0Xopenex 0.31 MG (as levalbuterol hydrochloride 0.36 MG) per 3 ML Inhalation SolutionSY7These highlights do not include all the information needed to use XOPENEX ® Inhalation Solution safely and effectively. See full prescribing information for XOPENEX ® Inhalation Solution. XOPENEX ® (levalbuterol hydrochloride) Inhalation Solution Initial U.S. Approval: 199920220914
7e2644e6-36c5-4988-8e52-bec90e2cd2f0levalbuterol 0.103 MG/ML Inhalation Solution [Xopenex]SBD7These highlights do not include all the information needed to use XOPENEX ® Inhalation Solution safely and effectively. See full prescribing information for XOPENEX ® Inhalation Solution. XOPENEX ® (levalbuterol hydrochloride) Inhalation Solution Initial U.S. Approval: 199920220914
7e2644e6-36c5-4988-8e52-bec90e2cd2f0Xopenex 0.31 MG in 3 ML Inhalation SolutionPSN7These highlights do not include all the information needed to use XOPENEX ® Inhalation Solution safely and effectively. See full prescribing information for XOPENEX ® Inhalation Solution. XOPENEX ® (levalbuterol hydrochloride) Inhalation Solution Initial U.S. Approval: 199920220914
7e2644e6-36c5-4988-8e52-bec90e2cd2f0Xopenex 0.103 MG/ML Inhalation SolutionSY7These highlights do not include all the information needed to use XOPENEX ® Inhalation Solution safely and effectively. See full prescribing information for XOPENEX ® Inhalation Solution. XOPENEX ® (levalbuterol hydrochloride) Inhalation Solution Initial U.S. Approval: 199920220914